Edition:
United States

People: OPKO Health Inc (OPK.O)

OPK.O on Nasdaq

2.11USD
17 Jul 2019
Change (% chg)

$0.01 (+0.48%)
Prev Close
$2.10
Open
$2.10
Day's High
$2.12
Day's Low
$2.05
Volume
2,477,213
Avg. Vol
4,606,464
52-wk High
$6.40
52-wk Low
$1.73

Hsiao, Jane 

Dr. Jane H. Hsiao, Ph.D., serves as Vice Chairman of the Board, Chief Technical Officer of the Company. Dr. Hsiao has served as Vice-Chairman and Chief Technical Officer of the Company since May 2007 and as a director since February 2007. Dr. Hsiao has served as Chairman of the Board of Non-Invasive Monitoring Systems, Inc. (OTC US:NIMU), a medical device company, since October 2008 and was named Interim Chief Executive Officer of Non-Invasive Monitoring Systems, Inc. in February 2012. Dr. Hsiao is also a director of each of TransEnterix, Inc. (NYSE American:TRXC), a medical device company, Neovasc, Inc. (NASDAQ CM:NVCN), a company developing and marketing medical specialty vascular devices, and Cocrystal Pharma, Inc. (NASDAQ GM:COCP). Dr. Hsiao served as the Vice Chairman-Technical Affairs of IVAX from 1995 to January 2006. Dr. Hsiao served as Chairman, Chief Executive Officer and President of IVAX Animal Health, IVAX’s veterinary products subsidiary, from 1998 to 2006.

Basic Compensation

Total Annual Compensation, USD 900,000
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,076,000
Fiscal Year Total, USD 1,976,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 112,500 186,750.00
Name Fiscal Year Total

Phillip Frost

2,036,000

Geoff Monk

--

Jane Hsiao

1,976,000

Adam Logal

1,250,000

Jon Cohen

--

Steven Rubin

1,460,000
As Of  30 Dec 2018